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Recently, there has been increasing interest in the use of non invasive ventilation (NIV) to increase exercise capacity.
In individuals with COPD, NIV during exercise reduces dyspnoea and increases exercise tolerance.
Different modalities of mechanical ventilation have been used non-invasively as a tool to increase exercise tolerance
in COPD, heart failure and lung and thoracic restrictive diseases. Inspiratory support provides symptomatic benefit
by unloading the ventilatory muscles, whereas Continuous Positive Airway Pressure (CPAP) counterbalances the
intrinsic positive end-expiratory pressure in COPD patients.
Severe stable COPD patients undergoing home nocturnal NIV and daytime exercise training showed some benefits.
Furthermore, it has been reported that in chronic hypercapnic COPD under long-term ventilatory support, NIV can
also be administered during walking.
Despite these results, the role of NIV as a routine component of pulmonary rehabilitation is still to be defined.
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During exercise in people with chronic obstructive pul-
monary disease (COPD), expiratory flow limitation and
increased respiratory frequency may reduce the expira-
tory time, resulting in increase in end-expiratory lung
volume, a condition also known as dynamic hyper-
inflation (DH). In such condition, tidal breathing takes
place at lung volumes closer to total lung capacity [1].
An unavoidable physiological consequence of DH is an
increase in the intrinsic positive end-expiratory pressure
(PEEPi) and in the elastic work of breathing (WOB): the
final result is severe dyspnoea during effort reducing the
exercise tolerance [2,3].
Pulmonary rehabilitation is a recognised core compo-
nent of the comprehensive management of COPD pa-
tients, mainly based on exercise training [4]. In patients
with chronic heart failure (CHF), exercise training has
beneficial direct and reflex sympatho-inhibitory effects
and favorable effects on normalisation of neurohumoral
excitation. These physiological benefits apply to all
COPD and CHF patients independently of the degree of* Correspondence: nico.ambrosino@gmail.com
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article, unless otherwise stated.disease severity and are associated with improved exer-
cise tolerance, functional capacity, and quality of life [5].
Recently, there has been an increasing interest in the
use of non invasive ventilation (NIV) to improve exer-
cise capacity [6-8], based on the evidence that assisted
ventilation, by unloading respiratory muscles, might
allow patients to train at higher levels of exercise inten-
sity. This review describes the present state of the art on
the use of NIV as a tool to increase the benefits of
pulmonary rehabilitation.Rationale
In a study on healthy trained cyclists it was shown that
the WOB required to sustain high-intensity exercise sig-
nificantly inversely correlated with leg blood flow [9,10].
In other words, during leg exercise, in conditions like
COPD where WOB increases, there may be a switch of
blood flow from limb to respiratory muscles, thus indu-
cing earlier limb muscle fatigue, a well known cause of
exercise interruption. This competition may be mini-
mised by adding assisted ventilation during exercise.
Confirming this hypothesis, in other studies assisted
ventilation prevented exercise-induced diaphragmatic fa-
tigue [11,12]. Because PEEPi and less effective inspira-
tory muscles in COPD contribute to dyspnoea, assistedCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Ambrosino and Cigni Multidisciplinary Respiratory Medicine  (2015) 10:14 Page 2 of 6ventilation should provide a symptomatic benefit by
unloading and assisting the overburdened inspiratory
muscles and reducing WOB. Unloading of the inspira-
tory muscles in turn may reduce their blood require-
ment allowing a switch of blood flow from respiratory to
limb muscles.
Another aspect may be important. Systemic inflamma-
tion has been related to the development of comorbidities
in COPD. The level of systemic inflammatory mediators is
increased in response to exercise in these patients [13].
Non invasive ventilation may prevent the interleukin-6 re-
sponse to exercise in muscle-wasted COPD patients [14].
Furthermore, sympathetic and parasympathetic neural
control of heart rate is deranged in COPD patients and
NIV acutely increases sympathetic response and decreases
vagal tonus: the increase in ventilation induced by NIV is
associated with reduced cardiac vagal activity in stable
moderate-to-severe COPD patients [15]. As a matter of
fact, it has been claimed that NIV may be useful to im-
prove exercise tolerance also in CHF [16].
Table 1 shows the suggested pathophysiological mech-
anisms of NIV effect during exercise.
Physiological studies
Different modalities of mechanical ventilation have been
delivered non-invasively by nasal, facial Masks or mouth-
piece during exercise [17].
Continuous positive airway pressure
Theoretically, CPAP should reduce the inspiratory thresh-
old load on the inspiratory muscles of hyperinflated
COPD patients and optimise neuromuscular coupling,
thus improving dyspnoea and exercise tolerance [18-20].
CPAP counterbalances, at least in part, PEEPi (ie, the
inspiratory threshold load) [21,22], reduces the WOB
and increases exercise tolerance also in people with cystic
fibrosis [23].
It has been suggested that the level of CPAP should be
titrated on an individual basis to optimise benefit and
comfort. Nevertheless, this implies the measurement of
PEEPi, which is difficult if not impossible to perform onTable 1 Suggested pathophysiological mechanisms for




Limb blood flow switch
Anti inflammatory action
Reduction in Vagal Tone
PEEP Reduction in iPEEP
Abbreviations: IPAP, Inspiratory Positive Airway Pressure; PEEP, Positive End Expiratory
Pressure; iPEEP, Intrinsic Positive End Expiratory Pressure; WOB: Work of Breathing.a routine basis [21]. CPAP seems also to be a useful
strategy to improve functional capacity in patients with
CHF, without any significant change in heart rate vari-
ability during physical exercises [24,25].
Inspiratory pressure support
Inspiratory Pressure Support (IPS) is a pressure-targeted
mode in which each breath is triggered and supported
by the patient [26]. This modality of mechanical ventila-
tion is able to assist ventilation effectively when applied
non-invasively in acute and chronic respiratory failure.
Pressure support can improve dyspnoea and exercise
capacity by reducing the high WOB of exercising COPD
patients [27-33]. Patients with severe COPD can sustain
exercise-induced lactatemia longer if assisted by means
of IPS [34]. Using near-infrared spectroscopy and im-
pedance cardiography to assess changes in cerebral oxy-
genation and cardiac output, it has been found that non
invasive IPS plus positive end expiratory pressure (PEEP)
added benefit to hyperoxia during exercise in improving
central haemodynamics and cerebral oxygenation in
COPD patients with exercise induced desaturations [35].
It has been also reported that during the walking test on
treadmill of cystic fibrosis patients, non invasive IPS
may change thoraco-abdominal kinematics and lung
function, improving exercise capacity suggesting that
NIV may be an effective tool to increase functional cap-
acity also in children and adolescents with cystic fibrosis
[36]. Non invasive IPS has been used also to improve
exercise tolerance in patients with restrictive ventilatory
pattern [37,38].
Proportional assist ventilation
Proportional Assist Ventilation (PAV) is a mode of par-
tial ventilatory assistance endowed with characteristics
of proportionality and adaptability to the intensity and
timing of spontaneous ventilatory pattern by providing
inspiratory flow and pressure in proportion to patient’s
effort [39]. PAV was proposed as a modality of mechan-
ical ventilation to improve the patient-ventilator inter-
action by bringing one of the two oscillatory pumps, the
mechanical ventilator, under the control of the other,
the patient’s central control of breathing [39]. Despite
the positive characteristics, this modality of mechanical
ventilation is still not used routinely in ICU. Several
laboratory studies show that also non invasive PAV can
increase exercise capacity of COPD patients without any
relevant haemodynamic effect [40-44] in idiopathic pul-
monary fibrosis (IPF) and obesity [45,46].
In a comparison study [45] submaximal test was in-
creased in IPF patients with PAV compared with CPAP
and without any ventilatory support. IPF patients perform-
ing submaximal exercise with PAV presented a lower
heart rate during exercise, although systolic and diastolic
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PAV applied during exercise led to increase in exercise en-
durance and reduction in dyspnoea also in obese patients
[46]. In these patients there was a large spectrum of re-
sponse to PAV, with more than 50% of patients increasing
their exercise endurance by a mean of 31%, thus suggest-
ing that PAV might be a novel treatment option to en-
hance exercise capacity in a subgroup of obese patients in
rehabilitation programs.
Controlled mechanical ventilation
Assist-control ventilation is a combination mode of venti-
lation in which the ventilator delivers a positive pressure
breath at a preset tidal volume in response to a patient’s
inspiratory effort. The ventilator also delivers breaths at a
preset rate if no patient effort occurs within the prese-
lected time period [47]. This modality of assisted ventila-
tion was delivered through nasal masks during exercise
in patients with pulmonary tuberculosis sequelae and
kyphoscoliosis, resulting in a significant improvement in
breathlessness and increase in exercise endurance [48,49].
Its use was not studied in COPD patients.
Non invasive ventilation in pulmonary rehabilitation programs
The message of these physiologic studies can be sum-
marised as follows: acute NIV, either as CPAP, IPS, or
PAV, during exercise reduces WOB and dyspnoea in-
creasing exercise tolerance in COPD patients and with
less level of evidence in restrictive disease patients [6].
The next step is to evaluate whether NIV can be used as
an aid during exercise training sessions. This is an im-
portant issue, because most patients with moderate to
severe COPD are candidates for pulmonary rehabilita-
tion programs (PRP) [4], and PRP are component of
the comprehensive management of majority of patients
facing lung transplantation or lung volume reduction
surgery [50,51].
One randomised controlled study [52] found no add-
itional benefit from providing NIV (in PAV modality)
during exercise training on bicycle, on exercise toler-
ance, dyspnoea, or health status when compared with
training alone. At difference, another similar study [53]
found that after a period of PAV-assisted training, mean
training intensity, and peak work rate were higher than
after unassisted training. Iso-workload lactataemia after
training was reduced to a greater extent in the assisted
than in unassisted patients. Moreover, a significant
inverse relationship was found between reduction in iso-
workload lactatemia after training during the constant
work rate test and peak work rate achieved during the
last week of training. This was considered as a marker of
true physiologic training effect.
In another study COPD patients were randomised into
three groups for an intervention of 12 weeks: exercisetraining alone, NIV alone and combined treatment. All
exercise capacity parameters improved after training and
the combined treatment. In addition, peripheral muscle
strength and six-minute walk distance (6MWD) increased
after NIV. Levels of interleukin 8 and tumour necrosis
factor α decreased after ventilation, and interleukin 8,
C-reactive protein and surfactant protein D decreased
after training, while all four of these inflammatory markers
fell after the combined treatment [54].
Other investigators have confirmed benefits of per-
forming NIV during exercise training as a part of PRP
[55-57].
There are some potential problems with the use of
NIV in PRP:
1. Interface. During high-intensity exercise, some
patients may breathe through their mouth rather
than (or together with) their nose, therefore they
may require a full-face mask or a mouthpiece.
Full-face masks may be more uncomfortable than
nasal masks, potentially reducing the patient’s
compliance to the procedure.
2. Comorbidities. Most of COPD patients have
significant comorbidities, including a high
prevalence of ischaemic cardiac disease [58]. The
relief of exercise dyspnoea induced by with this kind
of “mechanical doping” [59] might allow patients to
exercise at a higher intensity and, as such, expose
unaware ischaemic COPD patients to a load greater
than their coronary ischemic threshold.
3. Practicalities. In the study [52], there was a high
rate of drop-outs resulting from lack of compliance
in the group under NIV. Furthermore, a mean
17-minute time spent to set the ventilator and supervise
the training sessions with NIV was another practical
drawback to the use of NIV during a high-intensity
training program. It might not be practical or
worthwhile to submit patients to unpleasant
equipment (e.g., mask and related troubles), to
the need for constant supervision of an individual
operator to check for leaks and to reset the ventilator
when needed and to a substantial risk for lack of
patient compliance. The one-to-one patient therapist
ratio increases the costs of the PRP. In these days of
resource constraints this is a particularly important
concern, especially comparing with the recognised
benefits of well-conducted standard exercise training
programs not requiring complex and sophisticated
machinery or a personalised physiotherapist [4,6,59].
Night time NIV and day time exercise
Severe stable COPD patients undergoing home nocturnal
NIV and daytime exercise training showed a significant
improvement in exercise capacity and health related
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training alone [60-62].
Furthermore, it has been reported that, in chronic
hypercapnic COPD under long-term ventilatory support,
NIV can also be administered during walking, resulting
in improved oxygenation, decreased dyspnoea and in-
creased walking distance. Therefore, NIV during walking
could prevent hypoxia-induced complications [63,64].
Non invasive ventilation improves exercise tolerance
in patients with acute exacerbations of chronic respira-
tory diseases, but the applicability of this approach in
routine clinical practice may be limited [65,66]. In pa-
tients with restrictive disorders exercise training includ-
ing NIV was shown to be feasible at home, whatever the
modalities [67]. NIV alone is better than supplemental
oxygen alone in promoting beneficial physiologic adapta-
tions to physical exercise in patients with severe COPD
[68]. Recently, wearable devices have been introduced to
improve exercise tolerance of COPD patients [69].
Conclusions
Two recent meta-analyses concluded that, given the
small number of available studies, the small sample sizes,
and the complete absence of power calculation, there is
the need of randomised clinical trials with larger sample
sizes based on statistical power calculations and de-
signed to investigate the effect of training duration and
intensity on rehabilitation [70,71].
As application of NIV in rehabilitation programs is a
demanding tool in terms of heath resources, there is the
need to identify the best indications. Several questions
remain open:
1. Who is the ideal candidate ? Differences in results
of different studies may be explained on the basis
of different case mix, and apparently no study has
directly addressed the topic of the best indication.
Further studies are needed to identify the pathology
(obstructive vs restrictive; hypoxaemic vs
normoxaemic; hypercapnic vs normocapnic), the
patient type, (naive to NIV vs acclimated to NIV;
more vs less severely compromised patients).
2. Which are the most effective protocols? (e.g. training
alone, vs nocturnal NIV, vs NIV under exercise).
3. Which are the most appropriate outcome indices
to evaluate results? (e.g. tolerance to settings and
equipments; incremental vs endurance test vs field
test; Health Related Quality of Life vs dyspnoea vs
daily life activities).
Despite promising results, for the above reasons and
until the above questions are not answered, the authors
of this review believe that the use of NIV during exercise
training programs is unlikely to have a role in routinepulmonary rehabilitation settings. The use of NIV during
exercise training as a component of PRP should be
reserved to individual cases.
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